GlassScriptPhysician profile
Adriana S Tanner
NPI 1386684256
$133,549.32
in general payments reported to CMS, 2019-2025
14 companies · $60.88 in 2025
The $60.88 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $19K · 2021: $32K · 2022: $38K · 2023: $1,390 · 2024: $3,450 · 2025: $60.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,530 · Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,530.00 |
| Food and Beverage | $371.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $50,816.70 | 2020-2022 | |
| Eisai INC. | $32,447.34 | 2019-2023 | |
| Ucb, INC. | $26,979.84 | 2019-2025 | Fintepla, Briviact |
| Aquestive Therapeutics, INC. | $18,999.79 | 2019-2022 | |
| Livanova USA, INC. | $3,450.00 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Greenwich Biosciences, INC. | $316.50 | 2019-2021 | |
| Neuropace, INC. | $150.78 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Allergan, INC. | $124.99 | 2020 | |
| Sunovion Pharmaceuticals INC. | $45.14 | 2019-2020 | |
| Amgen INC. | $37.76 | 2019 | |
| Supernus Pharmaceuticals, INC. | $35.06 | 2019 | |
| Medtronic USA, INC. | $20.43 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriana Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.